Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
Myung-Chul Lee (Lee MC), Min Joo Kim (Kim MJ), Hoon Sung Choi (Choi HS), Sun Wook Cho (Cho SW), Guk Haeng Lee (Lee GH), Young Joo Park (Park YJ), Do Joon Park (Park DJ)
Endocrinol Metab. 2019;34(2):150-157.   Published online 2019 May 10     DOI: https://doi.org/10.3803/EnM.2019.34.2.150
Citations to this article as recorded by Crossref logo
Value of thyroglobulin post hemithyroidectomy for cancer: a literature review
Saam S. Tourani, Bill Fleming, Justin Gundara
ANZ Journal of Surgery.2021; 91(4): 724.     CrossRef
Pros and cons of hemi‐thyroidectomy for low‐risk differentiated thyroid cancer
Alexander J. Papachristos, Anthony Glover, Mark S. Sywak, Stan B. Sidhu
ANZ Journal of Surgery.2021; 91(9): 1704.     CrossRef
Management and follow-up of differentiated thyroid cancer not submitted to radioiodine treatment: a systematic review
Carla GAMBALE, Rossella ELISEI, Antonio MATRONE
Minerva Endocrinologica.2021;[Epub]     CrossRef
The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study
Yi Dou, Yingji Chen, Daixing Hu, Xinliang Su
Frontiers in Endocrinology.2021;[Epub]     CrossRef
Controversy: For or against thyroid lobectomy in > 1 cm differentiated thyroid cancer?
Fabrice Menegaux, Jean-Christophe Lifante
Annales d'Endocrinologie.2021; 82(2): 78.     CrossRef
Thyroid cancer, recent advances in diagnosis and therapy
Fadi Nabhan, Priya H. Dedhia, Matthew D. Ringel
International Journal of Cancer.2021; 149(5): 984.     CrossRef
A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol
Eun Kyung Lee, Yea Eun Kang, Young Joo Park, Bon Seok Koo, Ki-Wook Chung, Eu Jeong Ku, Ho-Ryun Won, Won Sang Yoo, Eonju Jeon, Se Hyun Paek, Yong Sang Lee, Dong Mee Lim, Yong Joon Suh, Ha Kyoung Park, Hyo-Jeong Kim, Bo Hyun Kim, Mijin Kim, Sun Wook Kim, Ka
Endocrinology and Metabolism.2021; 36(3): 574.     CrossRef
Long-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study
Yalin Zhu, Ying Che, Shuhang Gao, Shuangsong Ren, Mengying Tong, Lina Wang, Fang Yang
International Journal of Hyperthermia.2021; 38(1): 1225.     CrossRef
Optimal serum thyroid-stimulating hormone level for patients with papillary thyroid carcinoma after lobectomy
siyuan xu, ying huang, hui huang, xiaohang zhang, jiaxin qian, xiaolei wang, zhengang Xu, shaoyan liu, Jie Liu
Thyroid.2021;[Epub]     CrossRef
Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up
Soo Young Kim, Hee Jun Kim, Seok-Mo Kim, Hojin Chang, Yong Sang Lee, Hang-Seok Chang, Cheong Soo Park
Frontiers in Endocrinology.2020;[Epub]     CrossRef
Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer
Dana M. Hartl, Joanne Guerlain, Ingrid Breuskin, Julien Hadoux, Eric Baudin, Abir Al Ghuzlan, Marie Terroir-Cassou-Mounat, Livia Lamartina, Sophie Leboulleux
Cancers.2020; 12(11): 3282.     CrossRef
Annual Neck Ultrasonography Surveillance between 3 to 12 Years after Thyroid Lobectomy for Papillary Thyroid Microcarcinoma
Jin Gu Kang, Jung Eun Choi, Soo Jung Lee, Su Hwan Kang
International Journal of Thyroidology.2020; 13(2): 142.     CrossRef
Thyroid hormone therapy in differentiated thyroid cancer
Giorgio Grani, Valeria Ramundo, Antonella Verrienti, Marialuisa Sponziello, Cosimo Durante
Endocrine.2019; 66(1): 43.     CrossRef